Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 44.00
  • 52 Week Low: 3.20
  • Currency: UK Pounds
  • Shares Issued: 95.37m
  • Volume: 0
  • Market Cap: £3.58m
  • RiskGrade: 464

Latest ShareCast News

Fusion Antibodies gets first order under new services agreement

By Josh White

Date: Tuesday 27 Feb 2024

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Fusion Antibodies raises £1.38m as it seeks new customers

By Josh White

Date: Wednesday 14 Feb 2024

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Fusion Antibodies confirms £0.28m tax credit

By Josh White

Date: Thursday 01 Feb 2024

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Fusion Antibodies revenue falls, losses widen in... 04-Dec-2023 ShareCast
Fusion Antibodies appoints interim finance chief 24-Aug-2023 ShareCast
Fusion Antibodies progresses AI antibody collabo... 21-Aug-2023 ShareCast
Contract suspensions see Fusion Antibodies warn ... 06-Mar-2023 ShareCast
Fusion Antibodies confident after 'challenging' ... 05-Dec-2022 ShareCast
Fusion Antibodies reports strong full-year reven... 06-May-2022 ShareCast
Fusion Antibodies forms new scientific advisory ... 14-Jan-2022 ShareCast
Revenues rise, losses widen for Fusion Antibodies 06-Dec-2021 ShareCast
Fusion Antibodies signs collaborative deal with ... 07-Oct-2021 ShareCast
Fusion Antibodies performing in line in year-to-... 24-Sep-2021 ShareCast
Revenues rise, losses widen for Fusion Antibodies 10-Aug-2021 ShareCast
Fusion Antibodies receives first research milest... 23-Jul-2021 ShareCast
Fusion Antibodies soars on Covid-19 test progress 18-Sep-2020 ShareCast
Fusion Antibodies FY revenues continue to grow i... 06-Jul-2020 ShareCast
Fusion Antibodies raises £3m for Covid-19 research 28-Apr-2020 ShareCast
Fusion Antibodies sees 'favourable trends' conti... 29-Jan-2020 ShareCast
Fusion Antibodies cuts losses after revenue leaps 02-Dec-2019 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

FAB Market Data

Currency UK Pounds
Share Price 3.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 44.00
52 Week Low 3.20
Volume 0
Shares Issued 95.37m
Market Cap £3.58m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.59% below the market average44.59% below the market average44.59% below the market average44.59% below the market average44.59% below the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Price Trend
93.23% below the market average93.23% below the market average93.23% below the market average93.23% below the market average93.23% below the market average
94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average94.59% below the sector average
Income Not Available
Growth
21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

FAB Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page